Precision Cardiovascular Medicine & Population Genomics

Our mission is to transform cardiovascular care through genomic discovery and precision medicine implementation.

We harness the power of large-scale biobank data and advanced genomic analyses to uncover the genetic basis of cardiovascular diseases. Our work spans from initial discovery to clinical implementation, with a particular focus on atherosclerotic diseases, aortic conditions, and heart failure.

Through collaboration with the Million Veteran Program, Penn Medicine Biobank, and other major cohorts, we're identifying novel genetic variants that affect disease susceptiblity, which we use to develop new therapeutic targets and personalized prevention and treatment strategies that account for each individual's genetic risk profile.

Publications

70+ peer-reviewed publications

Trainees

10+ trainees mentored

Grants

3 active grant-funded projects

Target

IL-6 pathway advanced to clinical trials for PAD

Globe

Leading multi-center genomic studies

Flask

Novel therapeutic targets identified in AAA

Research Focus

Population Genetics

We leverage large-scale genetic association studies using biobank data to identify cardiovascular disease risk factors and therapeutic targets.

  • VA Million Veteran Program
  • Penn Medicine Biobank
  • UK Biobank
  • All of Us

Disease Areas

Our work spans the full spectrum of cardiovascular diseases, including:

  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Abdominal Aortic Aneurysm
  • Blood lipids
  • Heart Failure
  • Venous Thromboembolism
  • Varicose Veins

Translational Research

Implementation of genetic discoveries into clinical practice:

  • Polygenic risk scores
  • Mechanistic validation studies of new treatment targets
  • Predictive modeling
  • Precision prevention strategies

Current Projects

VA Career Development Award

Unraveling the Genetic Basis and Cardiovascular Impact of Lipoprotein(a) in Diverse Populations

2024-2029

Doris Duke Foundation Physician Scientist Award

Genetically Informed Targeting of Interleukin-6 Signaling to Treat Peripheral Artery Disease

2023-2025

News

Education & Training

University of Pennsylvania

MS in Translational Research

2021-Present

Hospital of the University of Pennsylvania

Cardiovascular Medicine Fellowship

2019-2023

Hospital of the University of Pennsylvania

Internal Medicine Residency

2016-2019

Rutgers New Jersey Medical School

MD

2012-2016

University of Pennsylvania

BA

2007-2011

Contact

Research Location

University of Pennsylvania Perelman School of Medicine
Division of Cardiovascular Medicine
3400 Civic Center Blvd.
Smilow 11-133
Philadelphia, PA 19104

Clinical Practice

Hospital of the University of Pennsylvania
Corporal Michael J. Crescenz VA Medical Center